Hostname: page-component-745bb68f8f-b95js Total loading time: 0 Render date: 2025-01-23T20:54:21.307Z Has data issue: false hasContentIssue false
  • English
  • Français

Familial Autoimmune Myasthenia Gravis: Four Patients Involving Three Generations

Published online by Cambridge University Press:  02 December 2014

R.A. Marrie ,
D.J. Sahlas  and
G.M. Bray
R.A. Marrie
Affiliation:
Division of Neurology, Montreal General Hospital, - McGill University, Health Centre, Montréal, Québec, Canada
D.J. Sahlas
Affiliation:
Division of Neurology, Montreal General Hospital, - McGill University, Health Centre, Montréal, Québec, Canada
G.M. Bray
Affiliation:
Division of Neurology, Montreal General Hospital, - McGill University, Health Centre, Montréal, Québec, Canada
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background:

Familial autoimmune myasthenia gravis (MG) is rare, although a genetic role for the development of autoimmune MG is suggested by concordance in monozygotic twins and the increased frequency of other autoimmune diseases in family members of myasthenics.

Methods:

A patient with a family history of MG was evaluated in hospital. Relatives were interviewed and medical records examined for details regarding the diagnosis of MG in three other family members.

Results:

The index case first experienced symptoms of MG at age 75 years. She developed generalized MG and required corticosteroids and immunosuppressive therapy to control her disease. Her father developed predominantly bulbar symptoms of MG at age 75 years. He died of complications experienced following a gastrostomy placed for continued difficulty swallowing. His brother developed similar symptoms of MG in his early 60s and died shortly after thymectomy. A 46-year-old nephew of the index case is also beginning to exhibit signs of generalized MG. Acetylcholine receptor antibodies were strongly positive in the index case and her nephew. (The assay was not available for her father and uncle).

Conclusion:

Four individuals in three successive generations had diagnoses of autoimmune MG. Study of familial cases such as these may clarify the contribution of genetic factors to the development of this disease.

Résumé:

RÉSUMÉ:Introduction:

La myasthénie grave (MG) familiale autoimmune est rare, bien que la concordance chez les jumeaux monozygotes et la fréquence accrue d'autres maladies autoimmunes chez les membres de la famille des myasthéniques suggèrent que la génétique joue un rôle dans le développement de la MG autoimmune.

Méthodes:

Un patient ayant une histoire familiale de MG a été hospitalisé pour une évaluation. La parenté a été questionnée et les dossiers médicaux ont été examinés concernant le diagnostic de MG chez trois autres membres de la famille.

Résultats:

Le cas index a présenté les premiers symptômes de MG à 75 ans. Elle a développé une MG généralisée et a eu besoin de corticostéroïdes et d'un traitement immunosuppresseur pour contrôler sa maladie. Son père avait développé des symptômes d'une MG à prédominance bulbaire à l'âge de 75 ans. Il est décédé de complications suite à une gastrostomie pour pallier à la dysphagie. Son frère a développé des symptômes similaires au début de la soixantaine et est décédé peu après une thymectomie. Un neveu du cas index, âgé de 46 ans, commence à présenter des signes de MG généralisée. Les anticorps dirigés contre le récepteur de l'acétylcholine étaient fortement positifs chez le cas index et son neveu. (Le test n'était pas disponible pour le père et l'oncle).

Conclusions:

Quatre individus sur trois générations successives ont reçu un diagnostic de MG autoimmune. L'étude de cas familiaux comme ceux-ci peut aider à déterminer la contribution de facteurs génétiques dans le développement de cette maladie.

Type
Research Article
Information
Canadian Journal of Neurological Sciences , Volume 27 , Issue 4 , November 2000 , pp. 307 - 310
Copyright
Copyright © The Canadian Journal of Neurological Sciences Inc. 2000

References

1. Vincent, A, Newland, C, Croxen, R, Beeson, D. Genes at the junction – candidates for congenital myasthenic syndromes. TINS 1997;20:15–22.Google Scholar
2. Murphy, J, Murphy, SF. Myasthenia gravis in identical twins. Neurology 1986;36:78–80.Google Scholar
3. Christensen, PB, Jensen, TS, Tsiropoulos, I, et al. Associated autoimmune diseases in myasthenia gravis. A population-based study. Acta Neurol Scand 1995;91:192–195.Google Scholar
4. Kerzin-Storrar, L, Metcalfe, RA, Dyer, PA, et al. Genetic factors in myasthenia gravis: a family study. Neurology 1988;38:38–42.Google Scholar
5. Zhiqiang, C. Familial myasthenia gravis. Report of 7 cases in 3 families. Chin Med J 1986;99:749–750.Google Scholar
6. Namba, T, Brunner, N, Brown, SB, Muguruma, M, Grob, D. Familial myasthenia gravis. Report of 27 patients in 12 families and review of 164 patients in 73 families. Arch Neurol 1971;25:61–72.Google Scholar
7. Honeybourne, D, Dyer, PA, Mohr, PD. Familial myasthenia gravis. J Neurol Neurosurg Psychiatry 1982;45:854–856.Google Scholar
8. Pirskanen, R. Genetic aspects in myasthenia gravis. Acta Neurol Scand 1977;56:365–388.Google Scholar
9. Bergoffen, J, Zmijewski, CM, Fischbeck, KH. Familial autoimmune myasthenia gravis. Neurology 1994;44:551–554.Google Scholar
10. Celesia, G. Myasthenia gravis in two siblings. Arch Neurol 1965;12:206–210.Google Scholar
11. Oppenheim, H. Diseases of nervous system, 2nd ed. Mayer, EE, trans. Philadelphia: J.B. Lippincott 1900:650.Google Scholar
12. Hokkanen, E, Emeryk-Szajewska, B, Rowinska-Marcinska, K. Evaluation of the jitter phenomenon in myasthenic patients and their relatives. J Neurol 1978;219:73–82.Google Scholar
13. Lefvert, AK, Pirskanen, R, Svanborg, E. Anti-idiotypic antibodies, acetylcholine receptor antibodies and disturbed neuromuscular function in healthy relatives to patients with myasthenia gravis. J Neuroimmunol 1985;9:41–53.Google Scholar
14. Pirskanen, R, Bergstrom, K, Hammarstrom, L, et al. Neuromuscular safety margin: genetical, immunological and electrophysiological determinants in relatives of myasthenic patients: a preliminary report. Ann NYAcad Sci 1981;377:606–613.Google Scholar
15. Seybold, ME, Lindstrom, JM. Antiacetylcholine receptor antibody and its relationship to HLA type in asymptomatic siblings of a patient with myasthenia gravis. Neurology 1981;31:778–780.Google Scholar
16. Evoli, A, Batocchi, AP, Zelano, G, et al. Familial autoimmune myasthenia gravis: report of four families. J Neurol Neurosurg Psychiatry 1995;58:729–731.Google Scholar
17. Tournier-Lasserve, E, Bach, J-F. The immunogenetics of myasthenia gravis, multiple sclerosis and their animal models. J Neuroimmunol 1993;47:103–114.Google Scholar